Ellen Kuenzig completed her Master’s in Epidemiology & Biostatistics from the University of Western Ontario in 2012 and her PhD in Epidemiology from the University of Calgary in 2016. Combining her experiences living with Crohn’s disease and her passion for better understanding IBD, her research during her PhD focused on genetic and environmental risk factors IBD. After finishing her PhD, Ellen began working as a post-doctoral fellow with Dr. Eric Benchimol at the Children’s Hospital of Eastern Ontario and ICES. Ellen received the AbbVie IBD Scholarship from Crohn’s and Colitis Canada, twice received a Student Research Prize from Crohn’s and Colitis Canada at Canadian Digestive Diseases Week, and the Pat Marten Memorial Prize from the Maternal and Child Health Working Group of the Canadian Association for Health Services and Policy Research. Her fellowship is funded through the Canadian Institutes of Health Research, Crohn’s and Colitis Canada, the Canadian Association of Gastroenterology, and Mitacs Canada. Ellen is the Principal Investigator on CanGIEC study investigating the trends in opioid use among people living with IBD and the impact of opioid use on these patients. She is also a co-Principal Investigator on the CanGIEC study describing the association between the urban exposome and the risk and outcomes of IBD.
Dr. Ellen Kuenzig
Investigator and Member, Scientific Committee